Filing Flows › Yarrow Bioscience (YARW) › Q2 2025
Yarrow Bioscience (YARW) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Yarrow Bioscience (YARW) reported revenue of $69K for the second quarter 2025 (Q2 2025), -65% from a year earlier and -66% from the quarter before.
Yarrow Bioscience, Q2 2025: revenue $69K (-65% year over year), net loss $5.8M, operating cash flow −$10.8M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $69K | -66% | -65% |
| Operating profit | −$7.5M | — | — |
| Net earnings | −$5.8M | — | — |
| Operating cash flow | −$10.8M | — | — |
What changed
Revenue was $69K in Q2 2025, down 65% year over year and down 66% from the previous quarter.
Operating costs exceeded revenue by $7.5M, an operating margin of -10930.4%. Total costs fell 28% while revenue fell 65%. The quarter ended with a net loss of $5.8M, narrower than the previous quarter's $8.6M loss. Non-operating items added $1.8M, -31% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$10.8M. Non-cash charges added back $6K of depreciation and $529K of share-based compensation. Working capital and other items used $5.6M.
Questions
What was Yarrow Bioscience's revenue in the second quarter 2025?
Yarrow Bioscience (YARW) reported revenue of $69K for the second quarter 2025 (Q2 2025), -65% from a year earlier and -66% from the quarter before.
Source: Yarrow Bioscience 10-Q on SEC EDGAR.